Description

CEFIXIME

• Prime choice for switch therapy owing to its very good efficacy
  and safety profile
• Potent beta-lactemase inhibitor

AZITHROMYCIN

• Broad spectrum coverage
• Approved by CDS & FDA
• Broad spectrum of actions against gram+ ve & gram-ve
  organisms including H.influenzae
• Decreases mucus production in purulent rhinitis